Delivery Order SPE2DB20D3103-SPE2DB25FP2A9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90 units, with a ceiling value of $8,606.87. This competitively awarded delivery order utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,446.65 delivery order on August 4, 2025, for the supply of Jardiance 25 mg tablets (90-count). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract is valued at $1,807.80 and utilizes firm fixed price terms. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract type. The order, valued at $4,520.58, is scheduled for completion by July 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designations, reflecting AmerisourceBergen's established capability to...
- The Defense Logistics Agency awarded a delivery order valued at $5,873.85 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $94,228.99 and is scheduled for completion by August 12, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) under a firm fixed price contract valued at $6,080.86. The order was competitively awarded without set-aside designation and carries an ultimate completion date of November 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply contract. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity, with a ceiling value of $7,604.31 and a firm fixed price contract type. This delivery order, which is non-set-aside and competitively awarded, is set to be completed by June 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- The Defense Logistics Agency awarded a delivery order valued at $11,275.03 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP2A9Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,133.25 on June 17, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract represents a non-set-aside procurement and is scheduled for completion by June 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor to the Defense Logistics Agency, AmerisourceBergen supplies a comprehensive range of medications and medical supplies supporting military healthcare systems and other federal customers. The Jardiance tablets being procured under this delivery order support pharmaceutical needs across the military healthcare supply chain, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts potentially involving multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 6/17/25 |